The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer.
- Assay Description:
- 1 hour incubation (RT) + 1 hour (RT) + 30 min. (RT) = 2 hours, 30 min. total incubation time
- Catalog number:
- 404-10US
- configuration:
- 96 Determinations, 12x8 removable strips
- controls:
- Not included but available for purchase - catalog # 108-20.
- design:
- Solid-phase, non-competitive immunoassay (ELISA) based upon the direct sandwich technique
- FDA Status:
- 510(k) cleared
- MSDS:
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Protocol:
- Sample types:
- Human serum
- Sample volume:
- 25 µL / determination
- standards:
- 6 calibrators, lyophilized
- Standard range:
- 15 - 900 pM
- storage:
- 2 - 8°C
- sensitivity:
- < 25 pM
- Species:
- Human
- Products related: